Breakthrough Victoria backs Neo-Bionica

Bioelectrical medical device developer Neo-Bionica has secured an investment of $5 million from Breakthrough Victoria, which will accelerate its growth both domestically and internationally. Neo-Bionica is a Melbourne advanced MedTech manufacturer that specialises in providing commercialisation and manufacturing services to develop AI-powered implantable and wearable medical devices. The company’’s expertise includes developing devices designed to…

BlockTexx closes $7 million Series B

Textile recycling company BlockTexx has announced completion of a $7 million Series B round. BlockTexx said in a statement that funding came from existing investors and fashion innovation platform, Fashion for Good. Return investors include Artesian and seed investors Mike and Sue Gregg. The company is scaling up its novel chemical process, which is able…

Breakthrough Victoria shells out $12 million for peanut allergy treatment developer Aravax

The Victorian government-funded Breakthrough Victoria has made a $12 million investment into Aravax, part of a $66 million funding round in the biotechnology company, which is developing a novel peanut allergy treatment. Aravax is a clinical-stage company developing PVX108, its immunotherapy product that uses synthetic peptides to mimic key parts of peanut proteins to retrain…

Uniseed expands horizons, seeks new investment managers

University investment group Uniseed is looking for new venture finance managers following its expansion, with five new universities backing its commercialising efforts. Uniseed is now searching for people to fill new roles of Investment Manager (Technology) in Melbourne and an Investment Manager (Biotechnology) in Sydney. Uniseed’s existing partners are the long established universities of Queensland,…